To cite this paper use one of the standards below:
Chaga’s Disease (CD), also known as American Trypanosomiasis, is caused by a flagellated protozoan Trypanosoma cruzi. WHO estimates that about six million people are infected with T. cruzi and more than 70 million people are at risk of transmission.1 The available therapy is focused in only two drugs: nifurtimox and benznidazole, which cause severe adverse side effects. In this context, our research group is involved in prospection of new bioactive compounds from Brazilian flora, specifically those with antitrypanosomal potential. Recent studies demonstrated that the n-hexane extract from leaves of Schinus terebinthifolius (Anacardiaceae) caused 100% of death of trypomastigotes at 200 g/mL. This extract was subjected to dereplication procedures using NMR, in which were observed the predominance of anacardic acid derivatives instead of tirucallane type triterpenes, commonly found in this plant.2 After bioactivity-guided procedures, was isolated pure anacardic acid (1) which structure was identified by analysis of NMR and MS data. To assist the chemical characterization of compound 1, two derivatives were prepared: hydrogenated (using H2/Pt - 1a) and tioalkylated (using Me2S2 - 1b). Compounds 1 and 1a were effective in killing the trypomastigotes forms of T. cruzi with IC50 values of 8.3 ± 0.7 and 9.0 ± 1.2 μM, respectively, while compound 1b and salicylic acid were inactives (IC50 > 200 μM). Comparatively, the IC50 to positive control benznidazole was determined as 18.7 ± 3.2 μM. Furthermore, no cytotoxicity at the highest tested concentration (CC50 > 200 µM) was observed to tested compounds. Due to the promising result with trypomastigote forms of T. cruzi, the mechanisms of parasite death caused by the treatment with bioactive compounds were investigated. The analysis of alteration in the cell membrane permeability by using the probe SYTOX green showed that compound 1 significantly altered this parameter after 40 min of incubation while compound 1a did not cause any alteration. Therefore, was suggested that the process of hydrogenation interfered with the action on the plasma membrane of the parasite, motivating us to perform additional assays to elucidate the mechanisms of parasitic death with compound 1a. Thus, the action of this derivative in the plasma membrane electric potential with the probe DisBAC2, after two hours of incubation, showed depolarization of this site (p > 0.05), verified by the increase of fluorescence levels when compared to untreated parasites. Differing from SYTOX Green, which shows deeper changes in the membrane, DiSBAC2 shows subtle membrane changes, related to ionic charge change. This probe enters in depolarized cells and bind to intracellular proteins, generating enhanced of fluorescence. The alteration in the plasma membrane was follow by the depolarization of the mitochondria, which is a single organelle in trypanosomatids, responsible for the ATP generation and consequent energy production for the parasite, thus being an important therapeutic target.3 Moreover, other parasite alterations, such as alteration in the ROS and Ca2+ levels were not observed after treatment with compound 1a. Therefore, the obtained results suggest that both tested compounds could be considered as candidate for future experimental preclinical assays against Chagas disease.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper